Stock listing
KRX:223250 DreamCIS, Inc. (드림씨아이에스) 주가
Follow DreamCIS, Inc. into a list and get an email when it puts out news.
Share price · KRX:223250
₩3,290.00 KRW +235.00 (+7.7%)
Close on Nov 20, 2026
- Day range
- ₩3,125.00 – ₩3,390.00 KRWNov 20, 2026
- Volume
- 382,253 sharesNov 20, 2026
- Market cap
- ₩80.94B KRWAt the close on Nov 20, 2026 · price × 24.60M shares outstanding
- 52-week range
- ₩2,360.00 – ₩8,640.00 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₩1.36B KRWMedian day 113,608 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:223250 · KRW, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₩3,290.00 | +235.00 | +7.7% | ₩3,210.00 | ₩3,390.00 | ₩3,125.00 | 382,253 | |
| ₩3,055.00 | +85.00 | +2.9% | ₩3,000.00 | ₩3,130.00 | ₩2,960.00 | 57,907 | |
| ₩2,970.00 | -145.00 | -4.7% | ₩3,015.00 | ₩3,165.00 | ₩2,815.00 | 198,141 | |
| ₩3,115.00 | -700.00 | -18.3% | ₩3,800.00 | ₩3,855.00 | ₩2,800.00 | 783,556 | |
| ₩3,815.00 | -20.00 | -0.5% | ₩3,880.00 | ₩3,895.00 | ₩3,730.00 | 74,571 | |
| ₩3,835.00 | -185.00 | -4.6% | ₩4,095.00 | ₩4,100.00 | ₩3,705.00 | 169,966 | |
| ₩4,020.00 | +120.00 | +3.1% | ₩3,915.00 | ₩4,140.00 | ₩3,890.00 | 112,770 | |
| ₩3,900.00 | +35.00 | +0.9% | ₩3,885.00 | ₩3,940.00 | ₩3,800.00 | 47,874 | |
| ₩3,865.00 | -185.00 | -4.6% | ₩4,005.00 | ₩4,035.00 | ₩3,855.00 | 71,095 | |
| ₩4,050.00 | +85.00 | +2.1% | ₩3,700.00 | ₩4,130.00 | ₩3,695.00 | 94,069 | |
| ₩3,965.00 | -35.00 | -0.9% | ₩4,025.00 | ₩4,170.00 | ₩3,895.00 | 106,820 | |
| ₩4,000.00 | +85.00 | +2.2% | ₩3,900.00 | ₩4,025.00 | ₩3,720.00 | 114,445 | |
| ₩3,915.00 | -60.00 | -1.5% | ₩3,875.00 | ₩4,060.00 | ₩3,840.00 | 61,925 | |
| ₩3,975.00 | -15.00 | -0.4% | ₩3,885.00 | ₩4,020.00 | ₩3,800.00 | 90,617 | |
| ₩3,990.00 | -10.00 | -0.3% | ₩4,150.00 | ₩4,200.00 | ₩3,880.00 | 326,617 | |
| ₩4,000.00 | +130.00 | +3.4% | ₩3,940.00 | ₩4,095.00 | ₩3,845.00 | 190,728 | |
| ₩3,870.00 | -85.00 | -2.1% | ₩3,965.00 | ₩4,045.00 | ₩3,870.00 | 213,546 | |
| ₩3,955.00 | +200.00 | +5.3% | ₩3,795.00 | ₩4,155.00 | ₩3,795.00 | 442,371 | |
| ₩3,755.00 | -410.00 | -9.8% | ₩4,150.00 | ₩4,195.00 | ₩3,695.00 | 487,957 | |
| ₩4,165.00 | +75.00 | +1.8% | ₩4,085.00 | ₩4,415.00 | ₩4,035.00 | 780,853 | |
| ₩4,090.00 | -145.00 | -3.4% | ₩4,270.00 | ₩4,575.00 | ₩4,010.00 | 820,496 | |
| ₩4,235.00 | +480.00 | +12.8% | ₩3,775.00 | ₩4,610.00 | ₩3,775.00 | 2,233,458 | |
| ₩3,755.00 | -220.00 | -5.5% | ₩3,955.00 | ₩4,040.00 | ₩3,735.00 | 156,259 | |
| ₩3,975.00 | +110.00 | +2.8% | ₩3,785.00 | ₩4,010.00 | ₩3,735.00 | 193,702 | |
| ₩3,865.00 | +340.00 | +9.6% | ₩3,525.00 | ₩4,025.00 | ₩3,500.00 | 599,388 | |
| ₩3,525.00 | -85.00 | -2.4% | ₩3,455.00 | ₩3,525.00 | ₩3,255.00 | 211,609 | |
| ₩3,610.00 | +80.00 | +2.3% | ₩3,505.00 | ₩3,720.00 | ₩3,500.00 | 110,147 | |
| ₩3,530.00 | +30.00 | +0.9% | ₩3,500.00 | ₩3,570.00 | ₩3,390.00 | 120,839 | |
| ₩3,500.00 | -380.00 | -9.8% | ₩3,885.00 | ₩3,885.00 | ₩3,480.00 | 258,213 | |
| ₩3,880.00 | +5.00 | +0.1% | ₩3,935.00 | ₩3,935.00 | ₩3,740.00 | 378,078 | |
| ₩3,875.00 | +185.00 | +5.0% | ₩3,690.00 | ₩4,085.00 | ₩3,690.00 | 782,298 | |
| ₩3,690.00 | +15.00 | +0.4% | ₩3,720.00 | ₩3,760.00 | ₩3,655.00 | 151,785 | |
| ₩3,675.00 | +55.00 | +1.5% | ₩3,620.00 | ₩3,760.00 | ₩3,500.00 | 463,020 | |
| ₩3,620.00 | +260.00 | +7.7% | ₩3,355.00 | ₩3,620.00 | ₩3,300.00 | 364,090 | |
| ₩3,360.00 | -55.00 | -1.6% | ₩3,405.00 | ₩3,425.00 | ₩3,350.00 | 124,821 | |
| ₩3,415.00 | -80.00 | -2.3% | ₩3,465.00 | ₩3,465.00 | ₩3,300.00 | 295,262 | |
| ₩3,495.00 | +205.00 | +6.2% | ₩3,400.00 | ₩3,700.00 | ₩3,375.00 | 939,332 | |
| ₩3,290.00 | -170.00 | -4.9% | ₩3,480.00 | ₩3,565.00 | ₩3,220.00 | 567,746 | |
| ₩3,460.00 | -170.00 | -4.7% | ₩3,630.00 | ₩3,640.00 | ₩3,400.00 | 1,146,469 | |
| ₩3,630.00 | +495.00 | +15.8% | ₩3,100.00 | ₩4,075.00 | ₩3,065.00 | 6,568,860 | |
| ₩3,135.00 | -45.00 | -1.4% | ₩3,195.00 | ₩3,235.00 | ₩3,080.00 | 51,866 | |
| ₩3,180.00 | +80.00 | +2.6% | ₩3,085.00 | ₩3,190.00 | ₩3,065.00 | 21,065 | |
| ₩3,100.00 | -90.00 | -2.8% | ₩3,195.00 | ₩3,205.00 | ₩3,040.00 | 36,331 | |
| ₩3,190.00 | -135.00 | -4.1% | ₩3,225.00 | ₩3,315.00 | ₩3,155.00 | 44,624 | |
| ₩3,325.00 | +25.00 | +0.8% | ₩3,300.00 | ₩3,330.00 | ₩3,195.00 | 29,653 | |
| ₩3,300.00 | -140.00 | -4.1% | ₩3,395.00 | ₩3,460.00 | ₩3,295.00 | 21,659 | |
| ₩3,440.00 | 0.00 | 0.0% | ₩3,470.00 | ₩3,490.00 | ₩3,335.00 | 41,046 | |
| ₩3,440.00 | -10.00 | -0.3% | ₩3,450.00 | ₩3,490.00 | ₩3,385.00 | 67,327 | |
| ₩3,450.00 | +70.00 | +2.1% | ₩3,380.00 | ₩3,455.00 | ₩3,345.00 | 35,850 | |
| ₩3,380.00 | -15.00 | -0.4% | ₩3,395.00 | ₩3,465.00 | ₩3,255.00 | 49,646 | |
| ₩3,395.00 | +95.00 | +2.9% | ₩3,300.00 | ₩3,400.00 | ₩3,235.00 | 25,433 | |
| ₩3,300.00 | -35.00 | -1.0% | ₩3,320.00 | ₩3,490.00 | ₩3,250.00 | 48,587 | |
| ₩3,335.00 | -75.00 | -2.2% | ₩3,410.00 | ₩3,410.00 | ₩3,275.00 | 28,084 | |
| ₩3,410.00 | 0.00 | 0.0% | ₩3,390.00 | ₩3,445.00 | ₩3,315.00 | 27,279 | |
| ₩3,410.00 | -70.00 | -2.0% | ₩3,445.00 | ₩3,470.00 | ₩3,280.00 | 43,501 | |
| ₩3,480.00 | +115.00 | +3.4% | ₩3,360.00 | ₩3,490.00 | ₩3,345.00 | 42,240 | |
| ₩3,365.00 | -115.00 | -3.3% | ₩3,410.00 | ₩3,450.00 | ₩3,365.00 | 84,111 | |
| ₩3,480.00 | -5.00 | -0.1% | ₩3,535.00 | ₩3,575.00 | ₩3,355.00 | 101,209 | |
| ₩3,485.00 | +125.00 | +3.7% | ₩3,330.00 | ₩4,025.00 | ₩3,290.00 | 538,187 | |
| ₩3,360.00 | +95.00 | +2.9% | ₩3,285.00 | ₩3,550.00 | ₩3,285.00 | 42,377 | |
| ₩3,265.00 | -75.00 | -2.2% | ₩3,340.00 | ₩3,340.00 | ₩3,170.00 | 53,654 | |
| ₩3,340.00 | +35.00 | +1.1% | ₩3,450.00 | ₩3,545.00 | ₩3,325.00 | 51,071 |
Splits
1 split · KRX:223250 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 4-for-1 | Split |
- Ticker
- KRX:223250
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- KRX
- Currency
- KRW
DreamCIS, Inc. on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
Valuation
P/E 246× against a median of 53.8×: the highest of 2 Diagnostics & research services companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₩44.70B KRW
- P/E
- 246×
- EV/sales
- 0.6×
- EV/EBITDA
- 5.4×
- Price/book
- 1.1×
- Gross margin
- 26.6%
- Operating margin
- 7.1%
- Net margin
- 0.4%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| DreamCIS, Inc. · KRX:223250 | US$60.13M | US$33.21M | 246× | 0.6× | 5.4× | 1.1× | 0.4% | 0.0× | n/a |
| Selvita SA · GPW:SLV | US$75.24M | US$113.4M | n/a | 1.4× | 9.1× | 1.0× | −0.6% | 0.5× | n/a |
| Sera Prognostics, Inc. · NASDAQ:SERA | US$69.65M | US$28.84M | n/a | 300× | n/a | 1.3× | n/a | 0.1× | 0.57 |
| BioPorto A/S · OMXCOP:BIOPOR | US$68.30M | US$58.06M | 53.8× | 10.7× | n/a | 5.7× | 23.3% | 0.1× | n/a |
| Nanoform Finland Oyj · OMXHEX:NANOFH | US$66.63M | US$52.80M | n/a | 11.9× | n/a | 1.7× | −339.1% | 0.2× | n/a |
| Applied BioCode Corp. · TWSE:6598 | US$64.88M | US$49.53M | n/a | 2.5× | n/a | 3.0× | −7.3% | 0.1× | n/a |
| Insight Molecular Diagnostics Inc. · NASDAQ:IMDX | US$64.53M | US$55.70M | n/a | 28.3× | n/a | n/a | n/a | n/a | 1.77 |
| Gentian Diagnostics ASA · OSL:GENT | US$62.79M | US$53.42M | n/a | 2.7× | 38.0× | 3.2× | −2.6% | 0.0× | n/a |
| Prestige Biologics Co., Ltd. · KRX:334970 | US$61.06M | US$72.08M | n/a | 3.6× | n/a | 0.9× | −192.1% | 0.2× | n/a |
| Champions Oncology, Inc. · NASDAQ:CSBR | US$60.41M | US$56.05M | n/a | 0.9× | 168× | 15.5× | −1.9% | 0.0× | 0.40 |
| Celemics, Inc. · KRX:331920 | US$49.18M | US$32.44M | n/a | 8.4× | n/a | 2.2× | −260.9% | 0.5× | n/a |
| Median of the others | US$64.71M | US$54.56M | 53.8× | 6.0× | 38.0× | 2.2× | −5.0% | 0.1× | 0.57 |
Forecasts
Analysts' consensus from EODHD, read Nov 21, 2026. Not 6ix's view and not investment advice.
- EPS, year to Dec 2026
- 439.00 · 1 analyst
- Revenue, year to Dec 2026
- 90B · 1 analyst
Events
| Quarter | Results | Share move |
|---|---|---|
| Q1 2026 | May 13, 2026 · Before open | +10.1% |
| Q3 2025 | Nov 12, 2025 · Before open | +0.9% |
| Q2 2025 | Aug 12, 2025 · Before open | −0.8% |
| Q1 2025 | May 14, 2025 · Before open | +1.3% |
| Q4 2024 | Mar 13, 2025 · After close | +1.4% |
| Q3 2024 | Nov 12, 2024 · After close | +1.6% |
| Q2 2024 | Aug 14, 2024 · After close | −0.5% |
| Q1 2024 | May 14, 2024 · After close | −7.5% |
| Q4 2023 | Mar 15, 2024 · After close | +3.5% |
| Q3 2023 | Nov 14, 2023 · After close | −0.6% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q2 2023 | Aug 11, 2023 · After close | −2.7% |
| Q1 2023 | May 12, 2023 · After close | +3.9% |
| Q4 2022 | Feb 15, 2023 | +2.6% |
| Q3 2022 | Nov 14, 2022 | +8.9% |
| Q2 2022 | Aug 16, 2022 · Before open | +1.8% |
| Q1 2022 | May 16, 2022 · Before open | +1.3% |
| Q4 2021 | Feb 18, 2022 · Before open | +2.4% |
| Q3 2021 | Nov 15, 2021 · Before open | +6.4% |
| Quarter to Jun 30, 2021 | Aug 13, 2021 · Before open | −2.0% |
| Quarter to Mar 31, 2021 | May 17, 2021 · Before open | −1.2% |
Financials
Annual, in KRW
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 66.6B | 58.7B | 47.8B | 38.9B | 26.2B | 23.5B | 22.1B | 19.2B | 16.0B |
| Cost of revenue | 47.3B | 40.8B | 34.9B | 25.0B | 17.5B | 13.9B | 13.7B | 12.3B | 13.6B |
| Gross profit | 19.4B | 17.9B | 12.9B | 13.9B | 8.69B | 9.62B | 8.40B | 6.89B | 2.34B |
| Research and development | 720.1M | 919.9M | 733.3M | 440.0M | 276.7M | 316.1M | |||
| Selling, general and administrative | 2.74B | 10.7B | 9.48B | 6.69B | 4.60B | 4.26B | 3.76B | 3.12B | 3.08B |
| Operating income | 5.24B | 5.06B | 1.59B | 5.73B | 3.62B | 4.79B | 4.34B | 3.57B | -1.05B |
| Depreciation and amortization | 2.83B | 1.68B | 1.47B | 1.33B | 934.0M | 956.4M | 576.8M | 181.3M | 194.6M |
| EBITDA | 8.07B | 6.74B | 3.06B | 7.07B | 4.56B | 5.75B | 4.91B | 3.75B | -857.0M |
| Interest expense | 303.7M | 199.3M | 191.0M | 144.4M | 88.4M | 36.8M | 0 | 0 | 0 |
| Income before tax | 10.9B | 6.18B | 4.41B | 5.16B | 3.95B | 4.90B | 4.49B | 3.64B | -1.01B |
| Income tax | 46.5M | ||||||||
| Net income | 7.13B | 5.28B | 3.74B | 4.41B | 3.23B | 4.85B | 4.15B | 3.42B | -1.12B |
| Earnings per share, basic | 299.44 | 221.86 | 157.70 | 191.14 | 147.86 | 872.04 | 1,031.60 | 849.31 | -278.29 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 22.3B | 22.7B | 5.80B | 8.95B | 3.49B | 4.17B | 5.83B | 6.06B | 3.16B |
| Short-term investments | 14.5B | 8.24B | 15.3B | 14.0B | 29.0B | 27.0B | 5.00B | 1000.0M | |
| Receivables | 20.1B | 15.0B | 6.00B | 7.60B | 4.93B | 3.50B | 10.5B | 8.63B | 8.27B |
| Inventory | 339.0M | 642.8M | 4.32M | ||||||
| Current assets | 79.3B | 66.5B | 42.1B | 41.8B | 46.4B | 43.1B | 22.9B | 16.8B | 12.0B |
| Property, plant and equipment | 5.26B | 5.41B | 5.82B | 4.80B | 1.13B | 1.01B | 180.8M | 252.7M | |
| Goodwill | 28.4B | 25.2B | 21.7B | 21.7B | |||||
| Total assets | 161.8B | 118.5B | 88.6B | 78.0B | 56.7B | 48.6B | 25.0B | 17.6B | 13.5B |
| Accounts payable | 1.63B | 1.17B | |||||||
| Current liabilities | 73.7B | 38.7B | 28.2B | 23.9B | 15.6B | 11.8B | 13.6B | 10.7B | 10.3B |
| Long-term debt | 0 | 0 | 0 | ||||||
| Total debt | 338.5M | 398.9M | |||||||
| Total liabilities | 76.0B | 50.6B | 31.7B | 29.0B | 18.7B | 12.1B | 14.3B | 11.1B | 10.7B |
| Shareholders' equity | 76.4B | 68.0B | 54.9B | 49.0B | 38.0B | 36.5B | 10.7B | 6.51B | 2.82B |
| Shares outstanding | 23.8M | 23.8M | 23.7M | 23.0M | 21.8M | 5.57M | 4.02M | 4.02M | 4.02M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 14.1B | -85.2M | 7.33B | 9.08B | 5.88B | 3.42B | 4.28B | 4.85B | 1.65B |
| Capital spending | -668.6M | -1.49B | -1.69B | -627.9M | -1.12B | -275.5M | -58.0M | -60.3M | -1.07M |
| Free cash flow | 13.4B | -1.58B | 5.65B | 8.46B | 4.76B | 3.09B | 4.22B | 4.79B | 1.65B |
| Cash from investing | 3.61B | -9.64B | -5.50B | -4.08B | -24.8B | -4.06B | -949.3M | 72.7M | |
| Cash from financing | 13.2B | -798.7M | 2.01B | -2.47B | 19.7B | -453.5M | -1.00B | -301.2M | |
| Share buybacks | 14.3B | 659.8M | 3.00B | -1.78B | 20.5B | -7.24M | |||
| Change in cash | -353.1M | 16.9B | -3.15B | 5.46B | -674.5M | -1.66B | -233.3M | 2.90B | 1.42B |
Cap table
Built by 6ix from DreamCIS, Inc.’s releases
- Common shares
- 24,600,444
- Fully diluted
- 24,600,444
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 24,600,444 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 24,600,444 |
Log in to ask 6ix AI your own questions about DreamCIS, Inc.